Imetelstat is an example of a telomerase inhibitor.
Based on the provided reference, one substance known to inhibit telomerase is Imetelstat. This drug has been studied in the treatment of several cancers and has shown positive results in patients with essential thrombocythemia and myelofibrosis, leading to hematological and molecular improvements. Imetelstat directly targets and inhibits the activity of telomerase.
- Imetelstat: This is a telomerase inhibitor studied in malignancies. It has shown hematological and molecular responses in essential thrombocythemia and myelofibrosis cases [71,72].
